Using either Bed Bath & Beyond, Inc's most current Form 10-k or the company's annual report, answer the following questions.

1. What is the book value of Bed Bath & Beyond's stockholders' equity thatbus shown on the companys balance sheet as of February 27,2021 (in thousands)?

2. What is the Par value of Bed Bath and Beyond's common stock?

3. How many shares of Bed Bath and Beyond's Preferred stock have been issued?

Their are no extra pictures or attatchments to help answer questions. Please google search Bed Bath and Beyond Current 10-k form or companys annual report to answer the questions listed above.

BED BATH & BEYOND INC. AND SUBSIDIARIES Consolidated Statements of Shareholders' Equity (in thousands) Accumulated Other Comprehensive Loss Total $(48,296) $2,888,628 (137,224) (10,314) (10,314) (4,221) (89,171) 60,657 (148,073) (58,610) 2,560,331 1613,816) (6,299) (6,299) (40.700) 183,545) 2.346 Additional Common Stock Pald-in Retained Treasury Stock Shares Amount Capital Earnings Shares Amount Balance at March 3, 2018 341,795 $3,418 $ 2,057,975 $ 11,343,503 1201.297) S (10,467,972) Net loss (137,224) Other comprehensive loss, net of tax Effect of Adoption of ASU 2014-09 (4,221) Dividend declared (89,171) Issuance of restricted shares.net 320 3 (3) Payment and vesting of performance stock units 464 5 (5) Stock-based compensation expense, net 60.657 Director fees paid in stock 3 49 Repurchase of common stock Including fees 19.052) (148,073) Balance at March 2, 2019 342,582 3,426 2,118,673 11,112,887 (210.349) (10,616,045) Net loss (613,816) Other comprehensive loss, net of tax Effect of Adoption of ASU 2016-02 (40.700) Dividend declared (83,545) Shares sold under employee stock option plans, net of taxes 139 1 2.345 Issuance of restricted shares, net 370 4 (4) Payment and vesting of performance stock units 580 5 15) Stock-based compensation expense.net 46,159 Director fees paid in stock 12 169 Repurchase of common stock including fees (6.806) 199,7101 Balance at February 29, 2020 343,683 3,436 2,167,337 10,374,826 (217.155) (10.715.755) Netloss (150,773) Other comprehensive loss, net of tax Dividend forfeited 1,200 Forfeiture of restricted shares, net (786) (8) Payment and vesting of performance stock units 344 4 14) Stock-based compensation expense.net 32,344 Accelerated share repurchase program (47.550) (15.833) (327,450) Repurchase of common stock, including fees (632) (5,079) Balance at February 27,2021 343,241 3,432 2,152.135 10,225.253 (233,620) (11,048,284) See accompanying Notes to Consolidated Financial Statements. 46,159 169 164.909) 199,710) 1,764,935 (150,773) 9.309 9,309 1,200 32,344 [375,000) 15.0791 (55,600) 1,276,936 BED BATH & BEYOND INC. AND SUBSIDIARIES Consolidated Statements of Cash Flows (in thousands) February 27, 2021 Twelve Months Ended February 29, 2020 March 2, 2019 Net loss $ (150,773) $ (613,816) $(137,224) 340,912 338,825 342,511 27,357 (29,690) (412) (77,038) 1,062 127,341 31,594 148,741 (396) 509,226 45,676 (145,543) (3,446) 509,905 58,514 (104,089) (814) 64,947 Cash Flows from Operating Activities: Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation and amortization Loss on sale leaseback transaction Gain on sale of building Gain on debt extinguishment Loss on sale of businesses including impairment of assets held for sale Goodwill and other impairments Stock-based compensation Deferred income taxes Other Decrease increase) in assets: Merchandise inventories Trading investment securities Other current assets Other assets (Decrease) increase in liabilities: Accounts payable Accrued expenses and other current liabilities Merchandise credit and gift card liabilities Income taxes payable Operating lease assets and liabilities, net Other liabilities Net cash provided by operating activities Cash Flows from Investing Activities: Purchases of held-to-maturity investment securities Redemption of held-to-maturity investment securities Net proceeds from sales of businesses Proceeds from sale-leaseback transaction Proceeds from sale of a building Capital expenditures Net cash provided by (used in) investing activities (387,172) 1,519 506,334 21 14,781) 218 106,928 86,277 269,186 218 168,556 15,538 (12,110) 54,958 (32,813) (26,758) 268,108 (124,206) 61,864 1,154 (22.783) (2,899) 14,054 590,941 (90,657) (77,147) 16,016 8,360 (35,918) 918,278 (443,500) 545,000 (734,424) 538,925 386,500 534,457 267,277 (183,077) $ 737,880 (277,401) 91,376 11.183 (325,366) $(509,682) $ February 27, 2021 Twelve Months Ended February 29, 2020 March 2, 2019 236,400 (457,827) (332,529) (47,550) (23,108) 17,690) (99,710) (4.224) (148,073) (85,482) (86,287) (632,304) 2,346 (182,846) (238,584) Cash Flows from Financing Activities: Borrowing of long-term debt Repayments of long-term debt Repurchase of common stock, including fees Prepayment under share repurchase agreement Payment of dividends Payment of deferred financing fees Proceeds from exercise of stock options Net cash used in financing activities Effect of exchange rate changes on cash, cash equivalents, and restricted cash Net increase in cash, cash equivalents and restricted cash Change in cash balances classified as held-for-sale Net increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash: Beginning of period End of period See accompanying Notes to Consolidated Financial Statements. (7,181) 162,831 5,075 378,759 4,815 383,574 (977) 498,494 (4,815) 493,679 162,831 1,023,650 $1,407,224 529,971 $ 1,023,650 367,140 $ 529,971